Cilostazol increases patency and reduces adverse outcomes in percutaneous femoropopliteal revascularisation: a meta-analysis of randomised controlled trials

por Benjo, Alexandre M, Garcia, Daniel C, Jenkins, J Stephen, Cardoso, Rhanderson M N, Molina, Taina P, El-Hayek, Georges E, Nadkarni, Girish N, Aziz, Emad F, Dinicolantonio, James J, Collins, Tyrone
Publicado 2014